Calliditas Therapeutics AB

Quick facts

Marketed products

• TARPEYO® · Other

Phase 3 pipeline

• NEFECON · Nephrology / Immunology
  Nefecon is a targeted immunosuppressant that delivers budesonide directly to the kidney to reduce inflammation in IgA nephropathy.

Phase 2 pipeline

• GKT137831

Phase 1 pipeline

• Xepol · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Calliditas Therapeutics AB portfolio CI brief
• Calliditas Therapeutics AB pipeline updates RSS